Clinical efficacy, safety, and success factors of botulinum toxin type A in the treatment of acute acquired comitant esotropia.
Abstract
[PURPOSE] Acute acquired comitant esotropia (AACE) is an increasingly reported form of esotropia, possibly linked to the rising use of digital devices. Botulinum toxin type A (BTXA) has emerged as a minimally invasive treatment alternative to surgery, particularly for patients with diplopia. We aimed to investigate the efficacy and safety of BTXA injections in treating AACE while identifying factors contributing to successful treatment outcomes.
[STUDY DESIGN] A retrospective, single-center study.
[METHODS] This study retrospectively evaluated 228 patients with AACE who received BTXA injections at a single center. Treatment outcomes, adverse events, and factors influencing success were analyzed. Successful outcomes were defined as either the absence of diplopia in the primary position or an angle of deviation of ≤10 prism diopters from orthotropia, both evaluated at more than 6 months after the last injection.
[RESULTS] The average patient age was 30.9 years, and 52% achieved successful outcomes. Transient adverse events, including blepharoptosis (24%) and hypertropia (16%), were observed. The study found that shorter duration from onset to treatment (P = 0.018) and post-treatment overcorrection (P = 0.0073) were associated with higher success rates. Although some patients required additional treatment or surgery due to recurrence, BTXA was an effective intervention for AACE, with a significant improvement in eye alignment and stereopsis.
[CONCLUSION] Early intervention with BTXA is crucial for successful outcomes and offers a safe, less invasive alternative to traditional strabismus surgery.
[STUDY DESIGN] A retrospective, single-center study.
[METHODS] This study retrospectively evaluated 228 patients with AACE who received BTXA injections at a single center. Treatment outcomes, adverse events, and factors influencing success were analyzed. Successful outcomes were defined as either the absence of diplopia in the primary position or an angle of deviation of ≤10 prism diopters from orthotropia, both evaluated at more than 6 months after the last injection.
[RESULTS] The average patient age was 30.9 years, and 52% achieved successful outcomes. Transient adverse events, including blepharoptosis (24%) and hypertropia (16%), were observed. The study found that shorter duration from onset to treatment (P = 0.018) and post-treatment overcorrection (P = 0.0073) were associated with higher success rates. Although some patients required additional treatment or surgery due to recurrence, BTXA was an effective intervention for AACE, with a significant improvement in eye alignment and stereopsis.
[CONCLUSION] Early intervention with BTXA is crucial for successful outcomes and offers a safe, less invasive alternative to traditional strabismus surgery.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 2 | |
| 해부 | eye
|
scispacy | 1 | ||
| 약물 | BTXA
→ Botulinum toxin type A
|
scispacy | 1 | ||
| 질환 | comitant esotropia
|
scispacy | 1 | ||
| 질환 | esotropia
|
C0014877
Esotropia
|
scispacy | 1 | |
| 질환 | diplopia
|
C0012569
Diplopia
|
scispacy | 1 | |
| 질환 | blepharoptosis
|
C0005745
Blepharoptosis
|
scispacy | 1 | |
| 질환 | hypertropia
|
C0020575
Hypertropia
|
scispacy | 1 | |
| 질환 | overcorrection
|
C0871026
Overcorrection (psychologic)
|
scispacy | 1 | |
| 질환 | strabismus
|
C0038379
Strabismus
|
scispacy | 1 | |
| 기타 | BTXA
→ Botulinum toxin type A
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 | ||
| 기타 | patient
|
scispacy | 1 |
📑 인용 관계
이 논문이 참조한 문헌 28
- Three-year Outcomes of Botulinum Toxin Versus Strabismus Surgery for the Treatment of Acute Acquired…
- A Comparison of Chemodnervation to Incisional Surgery for Acute, Acquired, Comitant Esotropia: An In…
- Botulinum toxin for the treatment of strabismus.
- The efficacy of botulinum toxin type A treatment and surgery for acute acquired comitant esotropia.
- Botulinum toxin treatment for bielschowsky acquired commitant esotropia in adults.
- Clinical efficacy of botulinum toxin type A on acute acquired comitant esotropia.
- Botulinum toxin injection without electromyographic guidance in consecutive esotropia.
- Functional acute acquired comitant esotropia: clinical characteristics and efficacy of single Botuli…
- Comparison of botulinum toxin with surgery for the treatment of acute acquired comitant esotropia an…
- Histopathological changes of fibrosis in human extra-ocular muscle caused by botulinum toxin A.
외부 PMID 18건 (DB 미수집)
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.